FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

Glenmark Pharmaceuticals Ciclopirox Gel 0 Recall

Ciclopirox Gel 0

Glenmark Pharmaceuticals Inc., USA · Mahwah, NJ

Risk level
Class III
Reported by FDA
Oct 9, 2024
Recall ID
D-0002-2025
Check your lot numberHow we source this data

Summary

Glenmark Pharmaceuticals recalled Ciclopirox Gel 0 starting Sep 30, 2024. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0002-2025 on Oct 9, 2024. Reason: Defective Container: Firm received complaints of broken tube at the seal. Status: Ongoing.

Why it was recalled

Defective Container: Firm received complaints of broken tube at the seal.

Product description

Ciclopirox Gel 0.77%, For Dermatologic Use Only, Not for Use in Eyes, Rx Only, a) 30 gm Tube, NDC 68462-0455-35; b) 45 gm Tube, NDC 68462-0455-47; c) 100 gm Tube, NDC 68462-0455-94, Manufactured by: Glenmark Pharmaceuticals, Ltd., Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430.

Lot numbers, UPCs & expiration codes

Lot #s: a) 19242028, Exp. 04/30/2026; b) 19242028, Exp. 04/30/2026; c) 19242028, Exp. 04/30/2026

Where it was sold

Nationwide in the US.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0002-2025
Classification
Class III
Status
Ongoing
Recall initiated
Sep 30, 2024
FDA report date
Oct 9, 2024
Quantity
11,568 tubes
Recall type
Voluntary: Firm initiated
Recalling firm
Glenmark Pharmaceuticals Inc., USA

Original FDA data

Every field from FDA enforcement report D-0002-2025, exactly as published.

Show all FDA fields
City
Mahwah
State
NJ
Status
Ongoing
Country
United States
Event ID
95444
Address
750 Corporate Dr
Code information
Lot #s: a) 19242028, Exp. 04/30/2026; b) 19242028, Exp. 04/30/2026; c) 19242028, Exp. 04/30/2026
Postal code
07430-2009
Report date
Oct 9, 2024
Product type
Drugs
Recall number
D-0002-2025
Classification
Class III
Recalling firm
Glenmark Pharmaceuticals Inc., USA
Product quantity
11,568 tubes
Reason for recall
Defective Container: Firm received complaints of broken tube at the seal.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ciclopirox Gel 0.77%, For Dermatologic Use Only, Not for Use in Eyes, Rx Only, a) 30 gm Tube, NDC 68462-0455-35; b) 45 gm Tube, NDC 68462-0455-47; c) 100 gm Tube, NDC 68462-0455-94, Manufactured by: Glenmark Pharmaceuticals, Ltd., Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430.
Distribution pattern
Nationwide in the US.
Recall initiation date
Sep 30, 2024
Center classification date
Oct 2, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0002-2025, published Oct 9, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls